Alterola Biotech, Inc. (ABTI) is a publicly traded company in the Healthcare sector, operating within the Drug Manufacturers - Specialty & Generic industry. The company is headquartered in Birkenhead, United Kingdom. The current CEO is David John Hitchcock.
ABTI has IPO date of 2010-05-05, 1 full-time employees, listed on the Other OTC, a market capitalization of $7.44M.
Alterola Biotech, Inc., a pharmaceutical company, engages in the development of cannabinoid and cannabinoid-like molecules. It focuses on the development of regulated human and animal health pharmaceuticals and regulated food products; production of active pharmaceutical ingredients and food-grade ingredients; and formulation and drug delivery for improved bioavailability, solubility, and stability. The company is based in Birkenhead, the United Kingdom.
